← brief for 2026-08-12 · Slowing decline

Kidney Week in Houston: Day 3 — NephJC

Page No results yet Not peer reviewed

Key takeaways

This is a conference roundup, not a single study. It covers late-breaking trials from a major kidney meeting. One tested sibeprenlimab, a new drug for IgA nephropathy. Another tested balcinrenone for chronic kidney disease. The blog summarizes what was presented; the full results sit in the linked journals.

Source

Page · Forager · 2026-08-13
https://www.nephjc.com/news/2025/11/8/kidney-week-in-houston-day-3